Track the 株式会社フェニックスバイオ stock price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社フェニックスバイオ has recorded 30 public disclosures. Market capitalisation: €1.4bn. The latest transaction was filed on 29 September 2025 (Holding update). Among the most active insiders: Whiz Partners Inc.. The full history is accessible without an account.
30
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
20Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,203 of 28,064 companies
63.6
score / 100
Value
65
Quality
62
FCF yld3.8%
Earn yld8.8%
EV/EBITDA11.2x
ROE8.6%
Gross mgn77%
Net mgn8.0%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.